AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (943 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells

Shi Liua,1, Yanmin Wua,1, Haiqiang Chena, Qi Yuana, Shuang Geb, Lishu Zhanga, Lingling Houa, Tian Tiana( ), Jinhua Zhanga( )
College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China
National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guangxi 530021, China

1 These authors contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Pages 344-347

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu S, Wu Y, Chen H, et al. MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells. Genes & Diseases, 2023, 10(2): 344-347. https://doi.org/10.1016/j.gendis.2022.04.021

681

Views

7

Downloads

3

Crossref

2

Web of Science

2

Scopus

0

CSCD

Received: 09 March 2022
Published: 18 May 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).